Latest CAXTON CORP Stock Portfolio
$4,024Thousand– No. of Holdings #7
CAXTON CORP Performance:
2026 Q1: 3.86%YTD: 3.86%2025: 70.38%
Performance for 2026 Q1 is 3.86%, and YTD is 3.86%, and 2025 is 70.38%.
About CAXTON CORP and 13F Hedge Fund Stock Holdings
On 2026-05-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, CAXTON CORP reported an equity portfolio of $4 Millions as of 31 Mar, 2026.
The top stock holdings of CAXTON CORP are GLD, , . The fund has invested 81.5% of it's portfolio in SPDR GOLD TR and 8.7% of portfolio in BERKSHIRE HATHAWAY INC DEL.
The fund managers got completely rid off SPYRE THERAPEUTICS INC (AGLE), MIND MEDICINE MINDMED INC (MNMD) and COMPASS THERAPEUTICS INC (CMPX) stocks. CAXTON CORP opened new stock positions in ALX ONCOLOGY HLDGS INC (ALXO). The fund showed a lot of confidence in some stocks as they added substantially to SPDR GOLD TR (GLD) and BERKSHIRE HATHAWAY INC DEL.
The top stock holdings of CAXTON CORP are GLD, , . The fund has invested 81.5% of it's portfolio in SPDR GOLD TR and 8.7% of portfolio in BERKSHIRE HATHAWAY INC DEL.
The fund managers got completely rid off SPYRE THERAPEUTICS INC (AGLE), MIND MEDICINE MINDMED INC (MNMD) and COMPASS THERAPEUTICS INC (CMPX) stocks. CAXTON CORP opened new stock positions in ALX ONCOLOGY HLDGS INC (ALXO). The fund showed a lot of confidence in some stocks as they added substantially to SPDR GOLD TR (GLD) and BERKSHIRE HATHAWAY INC DEL.
CAXTON CORP Equity Portfolio Value
Last Reported on: 14 May, 2026
CAXTON CORP Annual Return Estimates Vs S&P 500
Our best estimate is that CAXTON CORP made a return of 3.86% in the last quarter. In trailing 12 months, it's portfolio return was 166.14%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| alx oncology hldgs inc | 41,996 |
New stocks bought by CAXTON CORP
Additions
| Ticker | % Inc. |
|---|---|
| spdr gold tr | 9.46 |
| berkshire hathaway inc del | 2.39 |
Additions to existing portfolio by CAXTON CORP
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| compass therapeutics inc | -158,386 |
| context therapeutics inc | -27,053 |
| mind medicine mindmed inc | -210,058 |
| sab biotherapeutics inc | -39,371 |
| spyre therapeutics inc | -292,194 |
CAXTON CORP got rid off the above stocks
Sector Distribution
CAXTON CORP has about 96.2% of it's holdings in Others sector.
- Others
- Healthcare
| Sector | % |
|---|---|
| Others | 96.2 |
| Healthcare | 3.8 |
Market Cap. Distribution
CAXTON CORP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- UNALLOCATED
- MICRO-CAP
| Category | % |
|---|---|
| UNALLOCATED | 96.2 |
| MICRO-CAP | 3.8 |
Stocks belong to which Index?
About 2.6% of the stocks held by CAXTON CORP either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 97.4 |
| RUSSELL 2000 | 2.6 |
CAXTON CORP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of CAXTON CORP
CAXTON CORP has 7 stocks in it's portfolio. proved to be the most loss making stock for the portfolio. GLD was the most profitable stock for CAXTON CORP last quarter.
Last Reported on: 14 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| AGLE | spyre therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ALXO | alx oncology hldgs inc | 1.04 | 20,946 | 41,996 | new | |||
| CMPX | compass therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| CNTX | context therapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| GLD | spdr gold tr | 81.50 | 7,623 | 3,279,920 | added | 9.46 | ||
| IKT | inhibikase therapeutics inc | 1.19 | 28,453 | 47,801 | unchanged | 0.00 | ||
| MNMD | mind medicine mindmed inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SABS | sab biotherapeutics inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| XFOR | x4 pharmaceuticals inc | 1.60 | 15,557 | 64,249 | unchanged | 0.00 | ||
| berkshire hathaway inc del | 8.66 | 727 | 348,341 | added | 2.39 | |||
| kyverna therapeutics inc | 4.03 | 18,773 | 162,012 | unchanged | 0.00 | |||
| lexeo therapeutics inc | 1.99 | 13,943 | 80,032 | unchanged | 0.00 | |||